ADMA Biologics Inc (ADMA) Financials

ADMA Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 329.2 million 194.0 million
2023-09-30 349.0 million 197.6 million
2023-06-30 343.0 million 196.3 million
2023-03-31 340.8 million 195.1 million

ADMA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 16.2 million 1.7 million
2023-09-30 11.2 million 1.7 million
2023-06-30 -6.9 million 1.6 million
2023-03-31 -16.7 million 1.1 million

ADMA Net Income

No data available :(

ADMA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 51.4 million - 10.8 million
2023-09-30 74.2 million - 10.9 million
2023-06-30 62.5 million - 11.2 million
2023-03-31 69.2 million - 11.4 million

ADMA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 226.0 million
2023-09-30 225.3 million
2023-06-30 222.7 million
2023-03-31 221.9 million

ADMA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 1.4 million 445486 15.5 million -
2023-09-30 756557 595903 14.7 million -
2023-06-30 872633 1.4 million 15.6 million -
2023-03-31 1.9 million 855351 16.3 million -

ADMA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 73.9 million 43.0 million
2023-09-30 67.3 million 42.6 million
2023-06-30 60.1 million 43.4 million
2023-03-31 56.9 million 40.4 million

ADMA

Price: $6.92

52 week price:
3.06
6.92

Earnings Per Share: -0.13 USD

P/E Ratio: -48.11

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 2.7 million

Ebitda: -13.6 million

Market Capitalization: 1.4 billion

Links: